Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Joseph Barbieri
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Living Beings
Concepts & Ideas
Genes & Molecular Sequences
Anatomy
Phenomena
Sign-in to see full Profile
Network (preview)
13
Baldwin, Michael
12
Frank, Dara
9
Pederson, Kristin
7
Riese, Matthew
7
Deng, Qing
6
Aktories, Klaus
6
Chen, Sheng
6
Johnson, Eric
6
Sun, Jianjun
5
Yahr, TL
5
Zhang, Yue
5
Tepp, William
5
Kim, Jung-Ja
5
Maresso, Anthony
5
Mende-Mueller, LM
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Joseph Barbieri (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Salzameda Nicholas T; Barbieri Joseph T; Janda Kim D
Synthetic substrate for application in both high and low throughput assays for botulinum neurotoxin B protease inhibitors.
Bioorganic & medicinal chemistry letters 2009;19(20):5848-50.
-
2009: Baldwin Michael R; Barbieri Joseph T
Association of botulinum neurotoxins with synaptic vesicle protein complexes.
Toxicon : official journal of the International Society on Toxinology 2009;54(5):570-4.
-
2009: Chen Chen; Fu Zhuji; Kim Jung-Ja P; Barbieri Joseph T; Baldwin Michael R
Gangliosides as high affinity receptors for tetanus neurotoxin.
The Journal of biological chemistry 2009;284(39):26569-77.
-
2009: Rao Aparna R; Laxova Anita; Farrell Philip M; Barbieri Joseph T
Proteomic identification of OprL as a seromarker for initial diagnosis of Pseudomonas aeruginosa infection of patients with cystic fibrosis.
Journal of clinical microbiology 2009;47(8):2483-8.
-
2009: Chen Sheng; Barbieri Joseph T
Engineering botulinum neurotoxin to extend therapeutic intervention.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(23):9180-4.
-
2009: Henkel James S; Jacobson Mark; Tepp William; Pier Christina; Johnson Eric A; Barbieri Joseph T
Catalytic Properties of Botulinum Neurotoxin Subtypes A3 and A4 (dagger).
Biochemistry 2009;48(11):2522-8.
-
2008: Deng Qing; Barbieri Joseph T
Modulation of host cell endocytosis by the type III cytotoxin, Pseudomonas ExoS.
Traffic (Copenhagen, Denmark) 2008;9(11):1948-57.
-
2008: Chen Chen; Baldwin Michael R; Barbieri Joseph T
Molecular basis for tetanus toxin coreceptor interactions.
Biochemistry 2008;47(27):7179-86.
-
2008: Chen Sheng; Hall Cherisse; Barbieri Joseph T
Substrate recognition of VAMP-2 by botulinum neurotoxin B and tetanus neurotoxin.
The Journal of biological chemistry 2008;283(30):21153-9.
-
2008: Baldwin Michael R; Tepp William H; Przedpelski Amanda; Pier Christina L; Bradshaw Marite; Johnson Eric A; Barbieri Joseph T
Subunit vaccine against the seven serotypes of botulism.
Infection and immunity 2008;76(3):1314-8.
-
2008: Pier Christina L; Tepp William H; Bradshaw Marite; Johnson Eric A; Barbieri Joseph T; Baldwin Michael R
Recombinant holotoxoid vaccine against botulism.
Infection and immunity 2008;76(1):437-42.
-
2008: Deng Qing; Barbieri Joseph T
Molecular mechanisms of the cytotoxicity of ADP-ribosylating toxins.
Annual review of microbiology 2008;62():271-88.
-
2007: Deng Qing; Zhang Yue; Barbieri Joseph T
Intracellular trafficking of Pseudomonas ExoS, a type III cytotoxin.
Traffic (Copenhagen, Denmark) 2007;8(10):1331-45.
-
2007: Zhang Yue; Deng Qing; Porath Jaclyn A; Williams Carol L; Pederson-Gulrud Kristin J; Barbieri Joseph T
Plasma membrane localization affects the RhoGAP specificity of Pseudomonas ExoS.
Cellular microbiology 2007;9(9):2192-201.
-
2007: Chen Sheng; Barbieri Joseph T
Multiple pocket recognition of SNAP25 by botulinum neurotoxin serotype E.
The Journal of biological chemistry 2007;282(35):25540-7.
-
2007: Zhang Yue; Deng Qing; Barbieri Joseph T
Intracellular localization of type III-delivered Pseudomonas ExoS with endosome vesicles.
The Journal of biological chemistry 2007;282(17):13022-32.
-
2007: Baldwin Michael R; Barbieri Joseph T
Association of botulinum neurotoxin serotypes a and B with synaptic vesicle protein complexes.
Biochemistry 2007;46(11):3200-10.
-
2007: Chen Sheng; Kim Jung-Ja P; Barbieri Joseph T
Mechanism of substrate recognition by botulinum neurotoxin serotype A.
The Journal of biological chemistry 2007;282(13):9621-7.
-
2007: Eubanks Lisa M; Hixon Mark S; Jin Wei; Hong Sukwon; Clancy Colin M; Tepp William H; Baldwin Michael R; Malizio Carl J; Goodnough Michael C; Barbieri Joseph T; Johnson Eric A; Boger Dale L; Dickerson Tobin J; Janda Kim D
An in vitro and in vivo disconnect uncovered through high-throughput identification of botulinum neurotoxin A antagonists.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(8):2602-7.
-
2007: Baldwin Michael R; Kim Jung-Ja P; Barbieri Joseph T
Botulinum neurotoxin B-host receptor recognition: it takes two receptors to tango.
Nature structural & molecular biology 2007;14(1):9-10.
-
2007: Maresso Anthony W; Deng Qing; Pereckas Michael S; Wakim Bassam T; Barbieri Joseph T
Pseudomonas aeruginosa ExoS ADP-ribosyltransferase inhibits ERM phosphorylation.
Cellular microbiology 2007;9(1):97-105.
-
2006: Fu Zhuji; Chen Sheng; Baldwin Michael R; Boldt Grant E; Crawford Adam; Janda Kim D; Barbieri Joseph T; Kim Jung-Ja P
Light chain of botulinum neurotoxin serotype A: structural resolution of a catalytic intermediate.
Biochemistry 2006;45(29):8903-11.
-
2006: Boldt Grant E; Kennedy Jack P; Hixon Mark S; McAllister Laura A; Barbieri Joseph T; Tzipori Saul; Janda Kim D
Synthesis, characterization and development of a high-throughput methodology for the discovery of botulinum neurotoxin a inhibitors.
Journal of combinatorial chemistry 2006;8(4):513-21.
-
2006: Chen Sheng; Barbieri Joseph T
Unique substrate recognition by botulinum neurotoxins serotypes A and E.
The Journal of biological chemistry 2006;281(16):10906-11.
-
2005: Zhang Yue; Barbieri Joseph T
A leucine-rich motif targets Pseudomonas aeruginosa ExoS within mammalian cells.
Infection and immunity 2005;73(12):7938-45.
-
2005: Baldwin Michael R; Tepp William H; Pier Christina L; Bradshaw Marite; Ho Mengfei; Wilson Brenda A; Fritz Robert B; Johnson Eric A; Barbieri Joseph T
Characterization of the antibody response to the receptor binding domain of botulinum neurotoxin serotypes A and E.
Infection and immunity 2005;73(10):6998-7005.
-
2005: Deng Qing; Sun Jianjun; Barbieri Joseph T
Uncoupling Crk signal transduction by Pseudomonas exoenzyme T.
The Journal of biological chemistry 2005;280(43):35953-60.
-
2005: Corech R; Rao A; Laxova A; Moss J; Rock M J; Li Z; Kosorok M R; Splaingard M L; Farrell P M; Barbieri J T
Early immune response to the components of the type III system of Pseudomonas aeruginosa in children with cystic fibrosis.
Journal of clinical microbiology 2005;43(8):3956-62.
-
2005: Aktories Klaus; Barbieri Joseph T
Bacterial cytotoxins: targeting eukaryotic switches.
Nature reviews. Microbiology 2005;3(5):397-410.
-
2005: Rao A R; Splaingard M S; Gershan W M; Havens P L; Thill Andrew; Barbieri J T
Detection of Pseudomonas aeruginosa type III antibodies in children with tracheostomies.
Pediatric pulmonology 2005;39(5):402-7.
-
2005: Baldwin M R; Barbieri J T
The type III cytotoxins of Yersinia and Pseudomonas aeruginosa that modulate the actin cytoskeleton.
Current topics in microbiology and immunology 2005;291():147-66.
-
2004: Sun Jianjun; Barbieri Joseph T
ExoS Rho GTPase-activating protein activity stimulates reorganization of the actin cytoskeleton through Rho GTPase guanine nucleotide disassociation inhibitor.
The Journal of biological chemistry 2004;279(41):42936-44.
-
2004: Sun Jianjun; Maresso Anthony W; Kim Jung-Ja P; Barbieri Joseph T
How bacterial ADP-ribosylating toxins recognize substrates.
Nature structural & molecular biology 2004;11(9):868-76.
-
2004: Baldwin Michael R; Bradshaw Marite; Johnson Eric A; Barbieri Joseph T
The C-terminus of botulinum neurotoxin type A light chain contributes to solubility, catalysis, and stability.
Protein expression and purification 2004;37(1):187-95.
-
2004: Maresso Anthony W; Baldwin Michael R; Barbieri Joseph T
Ezrin/radixin/moesin proteins are high affinity targets for ADP-ribosylation by Pseudomonas aeruginosa ExoS.
The Journal of biological chemistry 2004;279(37):38402-8.
-
2004: Krall Rebecca; Zhang Yue; Barbieri Joseph T
Intracellular membrane localization of pseudomonas ExoS and Yersinia YopE in mammalian cells.
The Journal of biological chemistry 2004;279(4):2747-53.
-
2004: Barbieri J T; Sun J
Pseudomonas aeruginosa ExoS and ExoT.
Reviews of physiology, biochemistry and pharmacology 2004;152():79-92.
-
2003: Maresso Anthony W; Riese Matthew J; Barbieri Joseph T
Molecular heterogeneity of a type III cytotoxin, Pseudomonas aeruginosa exoenzyme S.
Biochemistry 2003;42(48):14249-57.
-
2003: Sun Jianjun; Barbieri Joseph T
Pseudomonas aeruginosa ExoT ADP-ribosylates CT10 regulator of kinase (Crk) proteins.
The Journal of biological chemistry 2003;278(35):32794-800.
-
2002: Maresso Anthony W; Barbieri Joseph T
Expression and purification of two recombinant forms of the type-III cytotoxin, Pseudomonas aeruginosa ExoS.
Protein expression and purification 2002;26(3):432-7.
-
2002: Pederson Kristin J; Krall Rebecca; Riese Matthew J; Barbieri Joseph T
Intracellular localization modulates targeting of ExoS, a type III cytotoxin, to eukaryotic signalling proteins.
Molecular microbiology 2002;46(5):1381-90.
-
2002: Fraylick Jennifer E; Riese Matthew J; Vincent Timothy S; Barbieri Joseph T; Olson Joan C
ADP-ribosylation and functional effects of Pseudomonas exoenzyme S on cellular RalA.
Biochemistry 2002;41(30):9680-7.
-
2002: Riese Matthew J; Barbieri Joseph T
Membrane localization contributes to the in vivo ADP-ribosylation of Ras by Pseudomonas aeruginosa ExoS.
Infection and immunity 2002;70(4):2230-2.
-
2002: Riese Matthew J; Goehring Udo-Michael; Ehrmantraut Mary E; Moss Joel; Barbieri Joseph T; Aktories Klaus; Schmidt Gudula
Auto-ADP-ribosylation of Pseudomonas aeruginosa ExoS.
The Journal of biological chemistry 2002;277(14):12082-8.
-
2002: Banwart Bruce; Splaingard Mark L; Farrell Philip M; Rock Michael J; Havens Peter L; Moss Joel; Ehrmantraut Mary E; Frank Dara W; Barbieri Joseph T
Children with cystic fibrosis produce an immune response against exoenzyme S, a type III cytotoxin of Pseudomonas aeruginosa.
The Journal of infectious diseases 2002;185(2):269-70.
-
2002: Krall Rebecca; Sun Jianjun; Pederson Kristin J; Barbieri Joseph T
In vivo rho GTPase-activating protein activity of Pseudomonas aeruginosa cytotoxin ExoS.
Infection and immunity 2002;70(1):360-7.
-
2002: Barbieri Joseph T; Riese Matthew J; Aktories Klaus
Bacterial toxins that modify the actin cytoskeleton.
Annual review of cell and developmental biology 2002;18():315-44.
-
2001: Riese M J; Wittinghofer A; Barbieri J T
ADP ribosylation of Arg41 of Rap by ExoS inhibits the ability of Rap to interact with its guanine nucleotide exchange factor, C3G.
Biochemistry 2001;40(11):3289-94.
-
2001: Würtele M; Renault L; Barbieri J T; Wittinghofer A; Wolf E
Structure of the ExoS GTPase activating domain.
FEBS letters 2001;491(1-2):26-9.
-
2001: Moss J; Ehrmantraut M E; Banwart B D; Frank D W; Barbieri J T
Sera from adult patients with cystic fibrosis contain antibodies to Pseudomonas aeruginosa type III apparatus.
Infection and immunity 2001;69(2):1185-8.
-
2001: Würtele M; Wolf E; Pederson K J; Buchwald G; Ahmadian M R; Barbieri J T; Wittinghofer A
How the Pseudomonas aeruginosa ExoS toxin downregulates Rac.
Nature structural biology 2001;8(1):23-6.
-
2000: Barbieri J T
Pseudomonas aeruginosa exoenzyme S, a bifunctional type-III secreted cytotoxin.
International journal of medical microbiology : IJMM 2000;290(4-5):381-7.
-
2000: Krall R; Schmidt G; Aktories K; Barbieri J T
Pseudomonas aeruginosa ExoT is a Rho GTPase-activating protein.
Infection and immunity 2000;68(10):6066-8.
-
2000: Pederson K J; Pal S; Vallis A J; Frank D W; Barbieri J T
Intracellular localization and processing of Pseudomonas aeruginosa ExoS in eukaryotic cells.
Molecular microbiology 2000;37(2):287-99.
-
1999: Goehring U M; Schmidt G; Pederson K J; Aktories K; Barbieri J T
The N-terminal domain of Pseudomonas aeruginosa exoenzyme S is a GTPase-activating protein for Rho GTPases.
The Journal of biological chemistry 1999;274(51):36369-72.
-
1999: Zhang L; Wang H; Masters S C; Wang B; Barbieri J T; Fu H
Residues of 14-3-3 zeta required for activation of exoenzyme S of Pseudomonas aeruginosa.
Biochemistry 1999;38(37):12159-64.
-
1999: Ganesan A K; Vincent T S; Olson J C; Barbieri J T
Pseudomonas aeruginosa exoenzyme S disrupts Ras-mediated signal transduction by inhibiting guanine nucleotide exchange factor-catalyzed nucleotide exchange.
The Journal of biological chemistry 1999;274(31):21823-9.
-
1999: Knight D A; Barbieri J T
Expression of FAS-independent ADP-ribosyltransferase activity by a catalytic deletion peptide of Pseudomonas aeruginosa exoenzyme S.
Biochemistry 1999;38(18):5858-63.
-
1999: Pederson K J; Vallis A J; Aktories K; Frank D W; Barbieri J T
The amino-terminal domain of Pseudomonas aeruginosa ExoS disrupts actin filaments via small-molecular-weight GTP-binding proteins.
Molecular microbiology 1999;32(2):393-401.
-
1999: Masters S C; Pederson K J; Zhang L; Barbieri J T; Fu H
Interaction of 14-3-3 with a nonphosphorylated protein ligand, exoenzyme S of Pseudomonas aeruginosa.
Biochemistry 1999;38(16):5216-21.
-
1999: Ganesan A K; Mende-Mueller L; Selzer J; Barbieri J T
Pseudomonas aeruginosa exoenzyme S, a double ADP-ribosyltransferase, resembles vertebrate mono-ADP-ribosyltransferases.
The Journal of biological chemistry 1999;274(14):9503-8.
-
1999: Radke J; Pederson K J; Barbieri J T
Pseudomonas aeruginosa exoenzyme S is a biglutamic acid ADP-ribosyltransferase.
Infection and immunity 1999;67(3):1508-10.
-
1999: Vallis A J; Yahr T L; Barbieri J T; Frank D W
Regulation of ExoS production and secretion by Pseudomonas aeruginosa in response to tissue culture conditions.
Infection and immunity 1999;67(2):914-20.
-
1998: Pederson K J; Barbieri J T
Intracellular expression of the ADP-ribosyltransferase domain of Pseudomonas exoenzyme S is cytotoxic to eukaryotic cells.
Molecular microbiology 1998;30(4):751-9.
-
1998: Yahr T L; Vallis A J; Hancock M K; Barbieri J T; Frank D W
ExoY, an adenylate cyclase secreted by the Pseudomonas aeruginosa type III system.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(23):13899-904.
-
1998: Schultz J E; Hsu A K; Barbieri J T; Li P L; Gross G J
Pertussis toxin abolishes the cardioprotective effect of ischemic preconditioning in intact rat heart.
The American journal of physiology 1998;275(2 Pt 2):H495-500.
-
1998: Truitt R L; Hanke C; Radke J; Mueller R; Barbieri J T
Glycosphingolipids as novel targets for T-cell suppression by the B subunit of recombinant heat-labile enterotoxin.
Infection and immunity 1998;66(4):1299-308.
-
1998: Ganesan A K; Frank D W; Misra R P; Schmidt G; Barbieri J T
Pseudomonas aeruginosa exoenzyme S ADP-ribosylates Ras at multiple sites.
The Journal of biological chemistry 1998;273(13):7332-7.
-
1997: Knight D A; Barbieri J T
Ecto-ADP-ribosyltransferase activity of Pseudomonas aeruginosa exoenzyme S.
Infection and immunity 1997;65(8):3304-9.
-
1997: Liu S; Yahr T L; Frank D W; Barbieri J T
Biochemical relationships between the 53-kilodalton (Exo53) and 49-kilodalton (ExoS) forms of exoenzyme S of Pseudomonas aeruginosa.
Journal of bacteriology 1997;179(5):1609-13.
-
1996: Finck-Barbançon V; Barbieri J T
Preferential processing of the S1 subunit of pertussis toxin that is bound to eukaryotic cells.
Molecular microbiology 1996;22(1):87-95.
-
1996: Yahr T L; Barbieri J T; Frank D W
Genetic relationship between the 53- and 49-kilodalton forms of exoenzyme S from Pseudomonas aeruginosa.
Journal of bacteriology 1996;178(5):1412-9.
-
1996: Liu S; Kulich S M; Barbieri J T
Identification of glutamic acid 381 as a candidate active site residue of Pseudomonas aeruginosa exoenzyme S.
Biochemistry 1996;35(8):2754-8.
-
1996: Xu Y; Barbieri J T
Pertussis toxin-catalyzed ADP-ribosylation of Gi-2 and Gi-3 in CHO cells is modulated by inhibitors of intracellular trafficking.
Infection and immunity 1996;64(2):593-9.
-
1995: Knight D A; Finck-Barbançon V; Kulich S M; Barbieri J T
Functional domains of Pseudomonas aeruginosa exoenzyme S.
Infection and immunity 1995;63(8):3182-6.
-
1995: Xu Y; Barbieri J T
Pertussis toxin-mediated ADP-ribosylation of target proteins in Chinese hamster ovary cells involves a vesicle trafficking mechanism.
Infection and immunity 1995;63(3):825-32.
-
1995: Finck-Barbançon V; Barbieri J T
ADP-ribosylation of alpha i3C20 by the S1 subunit and deletion peptides of S1 of pertussis toxin.
Biochemistry 1995;34(3):1070-5.
-
1995: Kulich S M; Frank D W; Barbieri J T
Expression of recombinant exoenzyme S of Pseudomonas aeruginosa.
Infection and immunity 1995;63(1):1-8.
-
1995: Krueger K M; Barbieri J T
The family of bacterial ADP-ribosylating exotoxins.
Clinical microbiology reviews 1995;8(1):34-47.
-
1994: Krueger K M; Barbieri J T
Assignment of functional domains involved in ADP-ribosylation and B-oligomer binding within the carboxyl terminus of the S1 subunit of pertussis toxin.
Infection and immunity 1994;62(5):2071-8.
-
1994: Kulich S M; Yahr T L; Mende-Mueller L M; Barbieri J T; Frank D W
Cloning the structural gene for the 49-kDa form of exoenzyme S (exoS) from Pseudomonas aeruginosa strain 388.
The Journal of biological chemistry 1994;269(14):10431-7.
-
1994: Xu Y; Barbançon-Finck V; Barbieri J T
Role of histidine 35 of the S1 subunit of pertussis toxin in the ADP-ribosylation of transducin.
The Journal of biological chemistry 1994;269(13):9993-9.
-
1994: Xu Y; Barbieri J T
Biochemical analysis of mutations at tyrosine-98 of the S1 subunit of pertussis toxin.
Biochemistry 1994;33(6):1573-9.
-
1993: Krueger K M; Barbieri J T
Molecular characterization of the in vitro activation of pertussis toxin by ATP.
The Journal of biological chemistry 1993;268(17):12570-8.
-
1993: Kulich S M; Frank D W; Barbieri J T
Purification and characterization of exoenzyme S from Pseudomonas aeruginosa 388.
Infection and immunity 1993;61(1):307-13.
-
1992: Barbieri J T; Armellini D; Molkentin J; Rappuoli R
Construction of a diphtheria toxin A fragment-C180 peptide fusion protein which elicits a neutralizing antibody response against diphtheria toxin and pertussis toxin.
Infection and immunity 1992;60(12):5071-7.
-
1992: Sandbaken M G; Runquist J A; Barbieri J T; Miziorko H M
Identification of the phosphoribulokinase sugar phosphate binding domain.
Biochemistry 1992;31(14):3715-9.
-
1991: Cortina G; Krueger K M; Barbieri J T
The carboxyl terminus of the S1 subunit of pertussis toxin confers high affinity binding to transducin.
The Journal of biological chemistry 1991;266(35):23810-4.
-
1991: Krueger K M; Mende-Mueller L M; Barbieri J T
Protease treatment of pertussis toxin identifies the preferential cleavage of the S1 subunit.
The Journal of biological chemistry 1991;266(13):8122-8.
-
1991: Cortina G; Barbieri J T
Localization of a region of the S1 subunit of pertussis toxin required for efficient ADP-ribosyltransferase activity.
The Journal of biological chemistry 1991;266(5):3022-30.
-
1990: Barbieri J T; Pizza M; Cortina G; Rappuoli R
Biochemical and biological activities of recombinant S1 subunit of pertussis toxin.
Infection and immunity 1990;58(4):999-1003.
-
1989: Barbieri J T; Mende-Mueller L M; Rappuoli R; Collier R J
Photolabeling of Glu-129 of the S-1 subunit of pertussis toxin with NAD.
Infection and immunity 1989;57(11):3549-54.
-
1989: Cortina G; Barbieri J T
Role of tryptophan 26 in the NAD glycohydrolase reaction of the S-1 subunit of pertussis toxin.
The Journal of biological chemistry 1989;264(29):17322-8.
-
1989: Barbieri J T; Moloney B K; Mende-Mueller L M
Expression and secretion of the S-1 subunit and C180 peptide of pertussis toxin in Escherichia coli.
Journal of bacteriology 1989;171(8):4362-9.
-
1988: Barbieri J T; Cortina G
ADP-ribosyltransferase mutations in the catalytic S-1 subunit of pertussis toxin.
Infection and immunity 1988;56(8):1934-41.
Sign-in to see more